- Home
- OTGA vs SENS Comparison
OTGA vs SENS Comparison
Compare OTGA & SENS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
N/A
HOLD
Current Price
$6.66
Company Overview
Basic Information| Metric | OTGA | SENS |
|---|---|---|
| Founded | 2025 | 1996 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Blank Checks | Industrial Machinery/Components |
| Sector | Finance | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 295.1M | 308.5M |
| IPO Year | N/A | 2014 |
Fundamental Metrics
Financial Performance| Metric | OTGA | SENS |
|---|---|---|
| Price | $10.08 | $6.66 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 4 |
| Target Price | N/A | ★ $18.38 |
| AVG Volume (30 Days) | 15.7K | ★ 339.8K |
| Earning Date | 01-01-0001 | 05-07-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $16,389,000.00 |
| Revenue This Year | N/A | $74.15 |
| Revenue Next Year | N/A | $58.60 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 19.85 |
| 52 Week Low | $9.97 | $0.41 |
| 52 Week High | $10.12 | $8.75 |
Technical Indicators
Market Signals| Indicator | OTGA | SENS |
|---|---|---|
| Relative Strength Index (RSI) | 62.82 | 50.03 |
| Support Level | $10.03 | $6.62 |
| Resistance Level | $10.10 | $6.87 |
| Average True Range (ATR) | 0.02 | 0.34 |
| MACD | 0.00 | 0.05 |
| Stochastic Oscillator | 66.67 | 64.20 |
Price Performance
Historical Comparison OTGA
SENS
About OTGA OTG Acquisition Corp. I Class A Ordinary Share
OTG Acquisition Corp I is a newly organized blank check company.
About SENS Senseonics Holdings Inc.
Senseonics Holdings Inc is a medical technology company. It is focused on the design, development, and commercialization of glucose monitoring system, which helps people to manage their diabetes community with differentiated, long-term implantable glucose management technology. Its products and services include a Continuous glucose monitoring system, Sensor, Smart transmitter, and Mobile app. The firm has a Glucose monitoring product segment. The majority of the revenue is generated outside of the United States.